Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
onCore UK Resource Report Resource Website 1+ mentions |
onCore UK (RRID:SCR_004348) | onCore UK | biomaterial supply resource, material resource | No longer functioning as an independent charity, onCore UK is a national cancer biobanking organization. Our mission is to serve as an action team that informs, coordinates and develops cancer biobanking to enable research towards the discovery and development of new interventions against cancer. We also offer advice to researchers who need to collect and store samples for their own specific projects. Our main strategic objectives are: * To empower research using human biosamples to find new and effective means of preventing, detecting or treating cancer. * To improve access by researchers to the human biosamples they require for their work. * To facilitate an environment in which patients, the public, health professionals, researchers, funders of research, policy makers and regulators can work together to support cancer biobanking and the research it underpins. * To provide practical information, coordination and development for current and future people and organizations involved in cancer biobanking to ensure that they are not unnecessarily hindered in their work. * To provide an accurate and regularly updated picture of the cancer biobanking provision in the UK that will inform future decisions by funders supporting research using donated human biosamples. * To distribute the human biosamples that onCore UK has in its custody. onCore UK conducts its business within the overall scope of the National Cancer Research Institute (NCRI) and for the benefit of cancer research. In the past we have also worked with selected NHS hospitals in different parts of the country to collect biosamples and relevant clinical data donated by cancer patients. These biosamples are stored in a secure repository and researchers can apply to use them. We make anonymized biosamples and data available for scientifically and ethically approved research on a cost-recovery basis. onCore UK works with other cancer biobanks in the UK via the NCRI Confederation of Cancer Biobanks (CCB), and with other biobanks internationally, to improve access for researchers to larger numbers of high quality biosamples, to harmonize how biobanks work and to share expertise for the benefit of all involved. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: National Cancer Research Institute is parent organization of: Confederation of Cancer Banks |
MRC ; Department of Health England ; Cancer Research UK |
nlx_36545 | SCR_004348 | 2026-07-25 12:12:29 | 1 | |||||||||
|
Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) Resource Report Resource Website 10+ mentions |
Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) (RRID:SCR_004226) | BBMRI | biomaterial supply resource, material resource | BBMRI is a pan-European and internationally broadly accessible research infrastructure and a network of existing and de novo biobanks and biomolecular resources. The infrastructure will include samples from patients and healthy persons, representing different European populations (with links to epidemiological and health care information), molecular genomic resources and biocomputational tools to optimally exploit this resource for global biomedical research. During the past 3 years BBMRI has grown into a 53-member consortium with over 280 associated organizations (largely biobanks) from over 30 countries, making it the largest research infrastructure project in Europe. During the preparatory phase the concept of a functional pan-European biobank was formulated and has now been presented to Member States of the European Union and for associated states for approval and funding. BBMRI will form an interface between specimens and data (from patients and European populations) and top-level biological and medical research. This can only be achieved through a distributed research infrastructure with operational units in all participating Member States. BBMRI will be implemented under the ERIC (European Research Infrastructure Consortium) legal entity. BBMRI-ERIC foresees headquarters (central coordination) in Graz, Austria, responsible for coordination of the activities of National Nodes established in participating countries. BBMRI is in the process of submitting its application to the European Commission for a legal status under the ERIC regulation, with an expected start date at the end of 2011. Major synergism, gain of statistical power and economy of scale will be achieved by interlinking, standardizing and harmonizing - sometimes even just cross-referencing - a large variety of well-qualified, up-to date, existing and de novo national resources. The network should cover (1) major European biobanks with blood, serum, tissue or other biological samples, (2) molecular methods resource centers for human and model organisms of biomedical relevance, (3) and biocomputing centers to ensure that databases of samples in the repositories are dynamically linked to existing databases and to scientific literature as well as to statistical expertise. Catalog of European Biobanks www.bbmriportal.eu Username: guest / Password: catalogue The catalogue is intended to be used as a reference for scientists seeking information about biological samples and data suitable for their research. The BBMRI catalogue of European Biobanks provides a high-level description of Europe''s biobanks characteristics using a portal solution managing metadata and aggregate data of biobanks. The catalogue can be queried by country, by biobank, by ICD-groups, by specimen types, by specific strengths, by funding and more. A search function is available for all data. | blood, serum, tissue, dna, cdna, rna, plasma, cell line, bodily fluid, urine, blood cell isolate, buffy coat, patient, healthy, normal, cryopreserved, paraffin embedded, clinical data |
is listed by: One Mind Biospecimen Bank Listing is related to: BioResource Impact Factor is related to: German Biobank Registry is related to: BioMedBridges is related to: Biological Resource Centre - National Institute for Cancer Research has parent organization: Medical University of Graz; Graz; Austria is parent organization of: BBMRI Wiki |
All, Patient, Healthy, Normal | European Union | Public: The catalogue is intended to be used as a reference for scientists seeking information about biological samples and data suitable for their research. | nlx_24389 | http://www.bbmri.eu/index.php | SCR_004226 | Biobanking and Biomolecular Resources Research Infrastructure, BBMRI: Biobanking Biomolecular Resources Research Infrastructure, Biobanking Biomolecular Resources Research Infrastructure, BBMRI: Biobanking and Biomolecular Resources Research Infrastructure, Biobanking Biomolecular Resources Research Infrastructure (BBMRI) | 2026-07-25 12:12:30 | 29 | ||||
|
Crimson Biospecimen Core Resource Report Resource Website |
Crimson Biospecimen Core (RRID:SCR_004451) | biomaterial supply resource, material resource | The Crimson Biospecimen Core prospectively collects discarded clinical materials matching investigator-defined criteria. Queries are run against real-time data on recently received clinical samples, including ICD.9 codes and results of clinical laboratory testing. Studies using the core must either (1) have an IRB-approved protocol for discarded clinical materials and anonymized information or (2) a protocol to allow collection of discarded samples from patients consented for their study. Collected samples may be additionally processed, aliquotted, or tested per the menu of tests available within the BWH and MGH Clinical Laboratories and Partners Genomics Center. Services: * Collection of discarded clinical specimens including serum, plasma, CSF, urine and microbiological isolates for IRB-approved studies. * Processing or additional clinical testing of collected materials. * Ability to receive consented patient samples for processing and clinical testing. * Online interface to manage collected sample inventories, associated test results, and study users/workgroup per IRB-approval. | is listed by: One Mind Biospecimen Bank Listing | nlx_44583 | SCR_004451 | 2026-07-25 12:12:31 | 0 | |||||||||||
|
US Biomax Resource Report Resource Website 50+ mentions |
US Biomax (RRID:SCR_004295) | US Biomax | biomaterial supply resource, material resource | Our robust searchable Tissue Bank database at US Biomax contains normal, non-cancerous disease and cancer samples, just a fraction of total paraffin tissue bank. Use advanced search function to define your search. Some of them have H&E images. Our tissue repository, tissue bank has huge paraffin tissue blocks, a large selection of histology tissue section slides of human cancer, normal tissue, rhesus and cynomolgus normal fresh frozen tissue as well as paraffin blocks and slides. It has also normal human organs in paraffin embedded tissue blocks as well as rhesus and cynomolgus monkey normal organ tissues. Snap frozen (fresh frozen) tissue of rhesus/cynomolgus monkey are also available. We also provide tissue array, custom tissue microarray (with samples you provided or from our tissue bank) as well as OEM services. Other products/services available include tissue microarray, paraffin tissue sections, histology services and quantitative telomerase detection kit. | FASEB list | is listed by: One Mind Biospecimen Bank Listing | nlx_31395 | SCR_004295 | US Biomax Inc. | 2026-07-25 12:12:31 | 89 | ||||||||
|
UTHealth BioBank Resource Report Resource Website |
UTHealth BioBank (RRID:SCR_004570) | CCTS BioBank | biomaterial supply resource, material resource | The University of Texas Health Science Center at Houston (UTHealth) Clinical and Translational Sciences (CCTS) BioBank employs a federated rather than a centralized model which encourages participation by sample owners who are concerned about guaranteeing their ownership of samples and sample information about patients, samples and related clinical data. In a federated model, individual sites agree on shared policies and procedures for data and sample sharing and oversight. Samples remain with and are governed by the contributing principal investigator at each site. The contributing investigator has final authority whether or not to collaborate or to release samples to qualified researchers. The goal of SLED (Sample Location and Enhanced Distribution) is to help researchers overcome two of the biggest obstacles preventing their research from beginning: 1) location of samples and related data, and 2) requesting of samples and related data. Prior to SLED''s inception the existing system was limited to providing links to samples and data and relying on phone calls to sample owners to facilitate sharing. Collaboration between the CTSA Biobank Consortium and the informatics team at the University of Texas School of Biomedical Informatics is ongoing during this effort. The initial design was constructed using best practices offered by NIH, NCI, and other biobank industry leaders to support and to improve synergy and interaction among various research efforts. Through SLED, researchers will be able to search for samples using a variety of criteria including availability, clinical data, consent criteria, patient demographics, patient diagnoses, study data, and sample type at local and national biobank sites. | clinical data |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Texas Health Science Center at Houston; Texas; USA |
All | Private / Collaborate / Public: Samples remain with and are governed by the contributing principal investigator at each site. The contributing investigator has final authority whether or not to collaborate or to release samples to qualified researchers. | nlx_62871 | SCR_004570 | CCTS Biomedical Informatics Group at UTHealth BioBank, UTHealth Clinical and Translational Sciences BioBank, Clinical and Translational Sciences BioBank, UTHealth CCTS BioBank | 2026-07-25 12:12:31 | 0 | ||||||
|
Accelerated Cure Project MS Repository Resource Report Resource Website |
Accelerated Cure Project MS Repository (RRID:SCR_004208) | biomaterial supply resource, material resource | A repository of biological samples and data from people with multiple sclerosis, selected other demyelinating diseases, and unaffected controls. The repository not only provides much-needed samples and data to researchers studying MS and other diseases, but also aggregates the results from all of these studies so that they can be analyzed collectively, leading to new findings and breakthroughs. The repository collects blood, DNA, and imaging once per year. The repository currently includes samples and data from over 2,700 subjects with Multiple Sclerosis, Neuromyelitis Optica, Acute Disseminated Encephalomyelitis, Transverse Myelitis, Optic Neuritis, and Clinically Isolated Syndromes, as well as controls. Blood samples are provided as aliquots as serum, plasma, DNA, RNA, and lymphocytes and each sample is accompanied by more than 40 pages of clinical and epidemiological data contributed by the subject and the enrolling neurologist. | multiple sclerosis, blood, dna, image, demyelinating disease, control, transverse myelitis, neuromyelitis optica, acute disseminated encephalomyelitis, optic neuritis, clinical data, epidemiological data, clinical, longitudinal |
lists: Biospecimens/Biorepositories: Rare Disease-HUB (RD-HUB) is listed by: One Mind Biospecimen Bank Listing is listed by: Multiple Sclerosis Discovery Forum is related to: Multiple Sclerosis Discovery Forum has parent organization: Accelerated Cure Project for Multiple Sclerosis |
Multiple Sclerosis, Demyelinating disease, Normal control, Transverse Myelitis, Neuromyelitis Optica, Acute Disseminated Encephalomyelitis, Optic Neuritis | Public: Samples and data are available to any researcher at any institution anywhere in the world, Those requesting samples and/or data must commit to contribute their results at a future date back into the repository | nlx_22946 | http://www.acceleratedcure.org/repository/index.php | SCR_004208 | Accelerated Cure Project Repository, Multiple Sclerosis (MS) Repository, ACP Repository | 2026-07-25 12:12:29 | 0 | ||||||
|
Autism-Spectrum Quotient Resource Report Resource Website |
Autism-Spectrum Quotient (RRID:SCR_003639) | AQ | assessment test provider, material resource | A 50 question psychological assessment that measures the symptoms of autism in adults, children and adolescents. | adult human, child, adolescent | Autism | Free | nlx_157818 | SCR_003639 | Autism Spectrum Quotient (AQ) | 2026-07-25 12:12:28 | 0 | |||||||
|
Social Phobia Inventory Resource Report Resource Website 1+ mentions |
Social Phobia Inventory (RRID:SCR_003673) | SPIN | assessment test provider, material resource | A 17-item self-administered assessment questionnaire developed by the Psychiatry and Behavioral Sciences Department at Duke University effective in screening for and measuring the severity of social anxiety disorder. Each question is answered with one of 5 responses ranging from Not at All to Extremely. Each response is assigned a score and then totaled at the end. Scoring: * 0-20 Little or No Anxiety * 21-30 Mild Anxiety * 31-40 Moderate Anxiety * 41-50 Severe Anxiety * 51-68 Very Severe Anxiety | questionnaire | Social anxiety disorder | Free | nlx_157827 | SCR_003673 | 2026-07-25 12:12:29 | 1 | ||||||||
|
Biobank Graz Resource Report Resource Website |
Biobank Graz (RRID:SCR_004245) | Biobank Graz | biomaterial supply resource, material resource | Biobank Graz is a non-profit central Medical University of Graz (MUG) service facility that provides the logistics and infrastructure to optimally support MUG research teams in the collection, processing and storage of biological samples and their associated data. In the course of this, special attention is given to sample and data quality and to the protection of the individual rights of patients. Samples from selected patients at the Graz LKH-University Clinical Centre, who have signed an informed consent declaration, are deposited in Biobank Graz. This means that excess tissue and blood samples are collected and placed in storage. The samples are harvested in the course of routine interventions undertaken by the different departments and institutes of the Graz LKH-University Clinical Centre and approved for use in research projects only after the completion of all necessary laboratory and histopathological analyses. No additional material is removed: in other words, there are no associated drawbacks whatsoever for the patients involved. Biobank Graz operates a quality management system according to ISO 9001:2008 and offers the following services for the processing and storage of biological samples and the handling of data: * Consistently high sample quality through the processing of samples using standardized methods in accordance with written working instructions (SOPs) * Efficient use of resources through the building of shared infrastructure and the development of optimized processes * A high degree of reliability provided by the storage of samples in 24/7 - monitored storage systems. * Processing and storage of all data in accordance with data protection legislation. Biobank Graz comprises both population-based and disease-focused collections of biological materials. It currently contains approx. 3.8 mio samples from approx. 1.2 mio patients representing a nonselected patient group characteristic of central Europe. Because the Institute of Pathology was, until 2003, the exclusive pathology service provider for major parts of the province of Styria, including its capital Graz (population approx. 1.2 mio people), samples from all human diseases, treated by surgery or diagnosed by biopsy, are included in the collection at their natural frequency of occurrence and thus represent cancers and non-cancerous diseases from all organs, and from all age groups. The scientific value of the existing tissue collection is, thus, not only determined by its size and technical homogeneity (all samples have been processed in a single institute under constant conditions for more than 20 years), but also by its population-based character. These features provide ideal opportunities for epidemiological studies and allow the validation of biomarkers for the identification of specific diseases and determination of their response to treatment. Prospectively collected tissues, blood samples and clinical data comprise, on the one hand, randomly selected samples from all diseases and patient groups to provide sufficient numbers of samples for the evaluation of the disease-specificity of any gene or biomarker. On the other hand, Biobank Graz adopts a disease-focused approach for selected diseases (such as breast, colon and liver cancers as well as some metabolic diseases) through the collection of a range of different human biological samples of highest quality and detailed clinical follow-up data. Graz Medical University established the Biobank to provide improved and sustainable access to biological samples and related (clinical) data both for its own academic research and for external research projects of academic and industrial partners. It is a major interest of the university to initiate co-operative research projects. Biological samples and data are available to external institutions performing high-quality research projects which comply with the Biobank''s ethical and legal framework according to the access rules (Contact: COO Karine Sargsyan, MD, PhD). | tissue, blood, dna, rna, serum, plasma, bodily fluid, urine, cryopreserved, formalin fixed paraffin embedded, csf, frozen, disease, population, patient, healthy, normal, clinical, patient, healthy, normal, disease, cancer, metabolic disease, breast cancer, colon cancer, liver cancer, clinical data, cerebral spinal fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Medical University of Graz; Graz; Austria |
All, Patient, Healthy, Normal, Disease, Cancer, Metabolic disease, Breast cancer, Colon cancer, Liver cancer | Public: Graz Medical University established the Biobank to provide improved and sustainable access to biological samples and related (clinical) data both for its own academic research and for external research projects of academic and industrial partners. It is a major interest of the university to initiate co-operative research projects. Biological samples and data are available to external institutions performing high-quality research projects which comply with the Biobank''s ethical and legal framework according to the access rules. | nlx_25894 | SCR_004245 | 2026-07-25 12:12:30 | 0 | |||||||
|
Marshfield Clinic Biobank Resource Report Resource Website |
Marshfield Clinic Biobank (RRID:SCR_004368) | PMRP bio-bank | biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 9, 2023. A large collection of biological samples and health information collected for the Personalized Medicine Research Project (PMRP) for use in biological research. Genetic information from 20,000 participants forms a database enabling scientists to study which genes cause disease, which genes predict reactions to drugs, and how environment and genes work together to cause disease. The goal of this project is to learn how to apply genetic science to human health. This knowledge will help researchers develop new medications and diagnostic tests, and will enable physicians to prescribe medications that work best for a particular person. Marshfield Clinic Personalized Medicine Research Project (PMRP) resources currently available: DNA, plasma, serum, questionnaire, electronic medical records to construct phenotypes; ability to recontact subjects for additional information (where they have given consent for recontact); stored pathology specimens collected for clinical purposes; 51 clinically relevant polymorphisms; Illumina 660 quad for ~4200 subjects aged 50+. | dna, adult human, blood, disease, gene, environment, questionnaire, electronic medical record, clinical, plasma, serum, drug, personalized medicine | is listed by: One Mind Biospecimen Bank Listing | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_38684 | http://www.marshfieldclinic.org/chg/pages/default.aspx?page=chg_pers_med_res_prj | SCR_004368 | Marshfield Clinic PMRP bio-bank, Personalized Medicine Research Project bio-bank, Marshfield Clinic Personalized Medicine Research Project bio-bank | 2026-07-25 12:12:31 | 0 | ||||||
|
Panic Disorder Severity Scale - Self-Report Resource Report Resource Website |
Panic Disorder Severity Scale - Self-Report (RRID:SCR_003671) | PDSS-SR | assessment test provider, material resource | A self-administered assessment used to detect possible symptoms of panic disorder and suggest the need for a formal diagnostic assessment. It consists of seven items (which are rated from 0-4). The items assess panic frequency, distress during panic, panic-focused anticipatory anxiety, phobic avoidance of situations, phobic avoidance of physical sensations, impairment in work functioning, and impairment in social functioning. The overall assessment is made by a total score, which is calculated by summing the scores for all seven items. The total scores range from 0 to 28. The PDSS-SR is used for screening and the scores 9 and above suggest the need for a formal diagnostic assessment. (Adapted from Wikipedia) | questionnaire | Panic Disorder | Free | nlx_157825 | SCR_003671 | Panic Disorder Severity Scale - Self rated, Panic Disorder Severity Scale (PDSS) Self-report | 2026-07-25 12:12:29 | 0 | |||||||
|
eyeGENE Resource Report Resource Website 10+ mentions |
eyeGENE (RRID:SCR_004523) | eyeGENE | biomaterial supply resource, material resource | National network of research laboratories for genetic testing of eye disease. They offer testing for affected individuals coupled to registry of clinical information available through patient registry. Large data set for investigators to identify additional genetic risk factors and to explore relationship between genetic disease (genotype) and its clinical manifestation (phenotype). | familial exudative vitreal retinopathy, fzd4, foxc1, abca4, aniridia, pax6, axenfeld - rieger syndrome, pitx2, best's disease, vmd2, bietti's crystalline corneal-retinal dystrophy, cyp4v2, c1qtnf5/ ctrp5, ca4, choroideremia, chm, cnga1, cone rod dystrophy, abca4, congenital cranial dysinnervation disease, kif21a, congenital stationary night blindness, nyx, corneal anterior stromal dystrophy, bigh3, crb1, doyne honeycomb dystrophy, efemp1, glaucoma, cyp1b1, hoxa1, impdh1, juvenile x-linked retinoschisis, xlrs1, krt12, lrp5, meesmann's epithelial dystrophy, krt3, mertk, myoc, ndp, optic atrophy, opa1, optn, pantothenate kinase-associated neuropathy, pank2, pattern dystrophy, rds, pde6a, pde6b, phox2a, prpf31, retinitis pigmentosa, retinal degeneration, abca4, rgr, rho, rlbp1, robo3, rp1, rp2, rpe65, rpgr, sall4, sorsby fundus dystrophy, timp3, stargardt disease, elovl4, tulp1, genotype, phenotype, diagnostic, genotyping, clinical trial, genetic eye disease, blood, dna, cell line, genetic testing, treatment, genetics, ophthalmic disease, eye |
is recommended by: National Library of Medicine is listed by: One Mind Biospecimen Bank Listing has parent organization: National Eye Institute (NEI) Commons |
Genetic eye disease, Family member | NEI | PMID:22847030 | Restricted | nif-0000-00229 | https://eyegene.nih.gov/node/38, https://eyegene.nih.gov/node/36 | SCR_004523 | eyeGENE, National Ophthalmic Disease Genotyping Network (eyeGENE), National Ophthalmic Disease Genotyping Network (eyeGENETM), National Ophthalmic Disease Genotyping Network | 2026-07-25 12:12:30 | 17 | |||
|
Autism Genetic Resource Exchange Resource Report Resource Website 1+ mentions |
Autism Genetic Resource Exchange (RRID:SCR_004403) | AGRE | biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 11, 2023. A private repository of clinical and genetic information on families with autism. Genetic and clinical data are obtained from families that have more than one family member diagnosed with an Autism Spectrum Disorder. The biological samples, along with the accompanying clinical data, are made available to AGRE-approved researchers worldwide. As they become available, additional family pedigrees will be posted in the online catalog. Cell lines have been established for the majority of families in this collection and serum/plasma is available on a subset of the subjects until stocks are depleted. The diagnosis of autism has been made using the standard Autism Diagnostic Interview-Revised (ADI-R) algorithm and the Autism Diagnostic Observation Scale (ADOS-G). Detailed birth and medical histories (including basic dysmorphology assessments) on children as well as family and medical information for parents and unaffected siblings, are available for nearly all families. DNA, cell lines, serum, plasma and clinical information are made available to AGRE-approved researchers for analysis. | family registry, gene bank, genetics, autism diagnostic, interview, autism diagnostic observational scale, autism spectrum disorder, birth, clinical data, genome scan, genotypic data, medical history, pedigree, phenotypic data, dna, cell line, serum, plasma, biorepository, biospecimen, pervasive development disorder |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Autism Speaks |
Autism, Autism spectrum disorder, Pervasive Development Disorder | NIMH 1U24MH081810 | PMID:20955925 | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-00226 | SCR_004403 | 2026-07-25 12:12:31 | 1 | |||||
|
Abbreviated Mental Test Score Resource Report Resource Website |
Abbreviated Mental Test Score (RRID:SCR_003677) | AMTS, AMT | assessment test provider, material resource | A 10 question assessment to assess elderly patients for the possibility of dementia. The test has utility across a range of acute and outpatient settings. It takes five minutes to administer and must include all 10 questions. A score of less than 7 or 8 suggests cognitive impairment. Scoring: * 7-10 (correct) No Cognitive Impairment * 6-0 (correct) Cognitive Impairment, THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | late adult human, memory, memory loss, confusion | has parent organization: Curtin University; Western Australia; Australia | Dementia, Cognitive impairment | PMID:23144286 PMID:4669880 |
THIS RESOURCE IS NO LONGER IN SERVICE | nlx_157830 | SCR_003677 | Abbreviated Mental Test | 2026-07-25 12:12:27 | 0 | |||||
|
Yale-Brown Obsessive Compulsive Scale Resource Report Resource Website |
Yale-Brown Obsessive Compulsive Scale (RRID:SCR_003676) | Y-BOCS | assessment test provider, material resource | Self-rating scale to assess the severity and type of symptoms in patients with obsessive-compulsive disorder (OCD). Each question is to be answered based on the average occurrence of each item over the past week. The first 5 questions relate to obsessive thoughts, the last 5 questions relate to compulsive behaviors. Scoring: * 07 Sub-Clinical * 815 Mild * 1623 Moderate * 2431 Severe * 3240 Extreme | Obsessive-Compulsive Disorder, Anxiety | Free | nlx_157829 | SCR_003676 | Yale-Brown Obsessive Compulsive Scale (Y-BOCS) | 2026-07-25 12:12:29 | 0 | ||||||||
|
UCSF DNA Bank Resource Report Resource Website |
UCSF DNA Bank (RRID:SCR_004248) | UCSF DNA Bank | biomaterial supply resource, material resource | The DNA Bank accepts the clinical samples from projects that have been approved by the Committee on Human Research (CHR). Genomic DNA isolation is performed utilizing standardized and quality controlled Gentra Systems'' PureGene DNA isolation system or Qiagen Kits. The quantity and quality of the genomic DNA isolate is determined by 260/280 UV spectrophotometery. Following isolation and quality assessment, DNA can be aliquoted into a normalized concentration. The preparation of aliquots serves to allow ready distribution of DNA samples to both the client laboratory and their collaborators and to preclude excessive routine freezing and thawing of the primary DNA isolate, a practice which is well known to result in notable degradation of genomic DNA stocks. All samples are stored in alarmed Revco ultra-low freezers at -80����?����?����?��������C. All of the ultra-low freezer units utilized by the DNA Bank are monitored by a temperature sensitive alarm system that provides 24 hour oversight. In the event of a power outage, all freezers are on an emergency back-up electrical generator. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of California at San Francisco; California; USA |
nlx_26337 | http://genomics.ucsf.edu/DNA_Bank/index.aspx | SCR_004248 | 2026-07-25 12:12:31 | 0 | |||||||||
|
NINDS Repository Resource Report Resource Website 1+ mentions |
NINDS Repository (RRID:SCR_004520) | biomaterial supply resource, material resource | Open resource of biological samples (DNA, cell lines, and other biospecimens) and corresponding phenotypic data to promote neurological research. Samples from more than 34,000 unique individuals with cerebrovascular disease, dystonia, epilepsy, Huntington's Disease, motor neuron disease, Parkinsonism, and Tourette Syndrome, as well as controls (population control and unaffected relatives) have been collected. The mission of the NINDS Repository is to provide 1) genetics support for scientists investigating pathogenesis in the central and peripheral nervous systems through submissions and distribution; 2) information support for patients, families, and advocates concerned with the living-side of neurological disease and stroke. | nervous system disorder, neurogenetics, genetic, clinical data, cerebrovascular disease, epilepsy, motor neuron disease, parkinson's disease, parkinsonism, tourette's disorder, normal control, stroke, amyotrophic lateral sclerosis, huntington's disease, dystonia, dementia, neurologically normal, blood, dna, biomarker, plasma, urine, cell line, induced pluripotent stem cell, fibroblast, stem cell, frozen, lymphoblast, biospecimen banking, biospecimen processing, biospecimen distribution, biospecimen, genetics, phenotype, neurological disease |
is listed by: One Mind Biospecimen Bank Listing is listed by: NeuroImaging Tools and Resources Collaboratory (NITRC) is related to: PD-DOC is related to: Parkinson’s Disease Biomarkers Program Data Management Resource (PDBP DMR) has parent organization: Coriell Cell Repositories |
Cerebrovascular disease, Epilepsy, Motor neuron disease, Parkinson's disease, Tourette's Disorder, Normal control, Stroke, Amyotrophic Lateral Sclerosis, Huntington's disease, Dystonia, Dementia, Neurologically normal, Neurological disorder | NINDS ; NIH Blueprint for Neuroscience Research |
Public | nlx_143800 | SCR_004520 | NINDS Human Genetics DNA Cell Line Repository, NINDS Human Genetics DNA and Cell Line Repository, The NINDS Repository, The NINDS Human Genetics Resource Center, The NINDS Human Genetics DNA and Cell Line Repository | 2026-07-25 12:12:31 | 3 | ||||||
|
CAGE Questionnaire Resource Report Resource Website |
CAGE Questionnaire (RRID:SCR_003702) | assessment test provider, material resource | 4-item questionnaire, where the name is an acronym of its four questions, that can indicate potential problems with alcohol abuse and has been extensively validated for use in identifying alcoholism. It has been determined that CAGE test scores >=2 had a specificity of 76% and a sensitivity of 93% for the identification of excessive drinking and a specificity of 77% and a sensitivity of 91% for the identification of alcoholism. The most important question in the questionnaire is the use of a drink as an Eye Opener, so much so that some clinicians use a yes to this question alone as a positive to the questionnaire; this is due to the fact that the use of an alcoholic drink as an Eye Opener denotes abuse since the patient is going through withdrawal in the morning, hence the need for a drink as an Eye Opener.(Adapted from Wikipedia) Scoring: * 2 (or more) yes responses indicates the possibility of alcoholism | alcohol abuse | Alcoholism, Alcohol-Related Disorder | Free | nlx_157854 | SCR_003702 | CAGE Alcohol Questionnaire | 2026-07-25 12:12:29 | 0 | ||||||||
|
Young Mania Rating Scale Resource Report Resource Website |
Young Mania Rating Scale (RRID:SCR_003700) | YMRS | assessment test provider, material resource | An eleven-item, multiple-choice diagnostic questionnaire which psychiatrists use to measure the severity of manic episodes in patients. The scale was originally developed for use in the evaluation of adult patients who were suffering from bipolar disorder, but has since been modified for use in pediatric patients. A similar scale was then developed to allow clinicians to interview parents about their children's symptoms, in order to ascertain a better diagnosis of mania in children. Clinical studies have demonstrated the effectiveness of the parent version of the scale. The scale provided is in a slightly reworded form as a self-assessment. This may not be as accurate when self-administered, as people suffering from mania are often unable to properly assess relevant outward symptoms. | adult human, pediatric, child, young human | Mania, Hypomanic system, Bipolar Disorder | Free | nlx_157851 | SCR_003700 | Young Mania Rating Scale (YMRS) | 2026-07-25 12:12:28 | 0 | |||||||
|
KORA-gen Resource Report Resource Website 1+ mentions |
KORA-gen (RRID:SCR_004510) | KORA-gen | biomaterial supply resource, material resource | KORA-gen is infrastructure to provide phenotypes, genotypes and biosamples for collaborative genetic epidemiological research. From all four surveys that have been conducted so far, the following biological material is on hand: genomic DNA, blood serum, blood plasma and EBV immortalized cell lines (form KORA S4 only). These have been extracted from blood samples and are stored in nitrogen tanks and -80 degrees C refrigerators. Genomic DNA from more than 18.000 adult subjects from Augsburg and the surrounding counties is available at present. So far, EBV immortalized cell lines from 1.600 participants are cultivated. To meet the manifold demands of researchers with genetic and molecular questions KORA-gen fulfills the following prerequisites for successful genetic-epidemiological research: * representative samples from the general population, * well characterized disease phenotypes and intermediate phenotypes, * information on environmental factors, * availability of genomic DNA, serum, plasma and urine, as well as EBV immortalized cell lines. In total, four population based health surveys have been conducted between 1984 and 2000 with 18000 participants in the age range of 25 to 74 years, and a biological specimen bank was established in order to enable scientists to perform epidemiologic research with respect to molecular and genetic questions. The KORA study center conducts regular follow-up investigations and has collected a wealth of information on sociodemography, general medical history, environmental factors, smoking, nutrition, alcohol consumption, and various laboratory parameters. This unique resource will be increased further by follow-up studies of the cohort. The assessment of statistical questions covers the definition of the study design and the calculation of statistical power. Furthermore, we offer assistance in data analysis. Kora-gen can be used by external partners. Interested parties can inform themselves interactively via internet about the available data and rules of access. The genotypic data base is a common resource to all partners. | gene, genetic, epidemiology, dna, serum, plasma, urine, cell line, epstein-barr virus immortalized cell line, blood, frozen, nitrogen, disease phenotype, adult human, survey, population study, genotype, phenotype |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Helmholtz Center Munich Institute of Epidemiology |
General population, Well characterized disease phenotype, Well characterized disease intermediate phenotype | Collaborators: Kora-gen can be used by external partners. Interested parties can inform themselves interactively via internet about the available data and rules of access. The genotypic data base is a common resource to all partners. | nlx_49266 | SCR_004510 | Cooperative Health Research in the Region of Augsburg-gen | 2026-07-25 12:12:31 | 8 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the kravitz2 Resources search. From here you can search through a compilation of resources used by kravitz2 and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that kravitz2 has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on kravitz2 then you can log in from here to get additional features in kravitz2 such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into kravitz2 you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Data set from Kravitz, Owen and Kretizer's 2012 paper "Optogenetic identification of striatal projection neuron subtypes during in vivo recordings."
